Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma

被引:0
|
作者
Giatromanolaki, A
Stathopoulos, GP
Tsiobanou, E
Papadimitriou, C
Georgoulias, V
Gatter, KC
Harris, AL
Koukourakis, MI
机构
[1] Tumour & Angiogenesis Res Grp, Iraklion 71306, Crete, Greece
[2] Univ Hosp Iraklion, Canc Biol Lab, Iraklion, Crete, Greece
[3] Hippokrateion Hosp, Dept Pathol & Oncol, Athens, Greece
[4] John Radcliffe Hosp, Dept Cellular Sci, Oxford OX3 9DU, England
[5] John Radcliffe Hosp, Imperial Canc Res Fund, Med Oncol Unit, Oxford OX3 9DU, England
关键词
angiogenesis; p53; bcl-2; CD31; colorectal carcinoma;
D O I
10.1002/(SICI)1097-0142(19991015)86:8<1421::AID-CNCR6>3.0.CO;2-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. The objective of this study was to evaluate intratumoral neoangiogenesis in Dukes Stage B and Stage C (AJCC/UICC Stage I and III) colorectal adenocarcinoma and its correlation with nuclear p53 oncoprotein accumulation and cytoplasmic bcl-2 expression as well as to assess the prognostic significance of these features in patient outcome. METHODS, Paraffin embedded specimens from 55 patients with Dukes Stage B (AJCC/UICC Stage I) and 51 patients with Dukes Stage C (AJCC/UICC Stage III) colorectal adenocarcinoma who were treated with surgery were assessed. Patients with lymph node involvement (Dukes Stage C [AJCC/UICC Stage III]) also were treated with postoperative pelvic radiotherapy and adjuvant chemotherapy with 5-fluorouracil and leucovorin with or without interferon-alpha. Immunohistochemistry was performed using the anti-CD31 monoclonal antibody (MoAb) for vessel staining, the DO7 MoAb for nuclear p53 expression, and the clone 124 for cytoplasmic/ perinuclear bcl-2 expression. Patient follow-up ranged from 4-70 months (median, 28 months). RESULTS, High vascular grade (microvessel score [MS] greater than or equal to 40) was observed in 39 of 106 specimens (37%), a medium MS (16-39) was observed in 29 of 106 cases (27%), and a low MS (7-15) was observed in 38 of 106 cases (36%). Positive expression of the bcl-2 protein in > 10% of cells was observed in 33 of 106 cases (31%), whereas p53 nuclear oncoprotein accumulation in > 10% of cells occurred more frequently (44 of 106 cases [42%]). No correlation among p53 expression, bcl-2 expression, and vascular grade was observed. Stroma infiltration by CD31 positive lymphocytes was associated strongly with increased vessel density (P = 0.0001). In univariate analysis Dukes stage was the only significant prognostic parameter (P = 0.02), whereas p53 and vascular grade showed marginal prognostic significance (P = 0.07 and P = 0.09, respectively). In Dukes Stage C (AJCC/UICC Stage III) patients, high vascular grade was the only parameter that predicted a worse overall survival (P = 0.04). Double stratification showed that patients with high vascular grade and positive p53 expression had a poorer survival (P = 0.03). CONCLUSIONS. The results of the current study suggest that p53 mutations, loss of bcl-2 expression, and tumor angiogenesis are events linked to the processes of metastases and local invasion in patients with colorectal carcinoma. Increased vascularization appears to be the most important prognostic factor in patients with Dukes Stage C (AJCC/UICC Stage III) colorectal adenocarcinoma. (C) 1999 American Cancer Society.
引用
收藏
页码:1421 / 1430
页数:10
相关论文
共 50 条
  • [1] Combined Role of Tumor Angiogenesis, bcl-2, and p53 Expression in the Prognosis of Patients With Colorectal Carcinoma. (vol 86, pg 1421, 1999)
    Giatromanolaki, A.
    Stathopoulos, G. P.
    Tsiompanou, Eleni
    Papadimitriou, C.
    Georgoulias, V
    Gatter, K. C.
    Harris, A. L.
    Koukourakis, M., I
    CANCER, 2009, 115 (17) : 4040 - 4040
  • [2] Expression of p53 and bcl-2 in adenomas and colorectal carcinoma
    Sundblad, AS
    Chumbita, RL
    Zoppi, JA
    MEDICINA-BUENOS AIRES, 1997, 57 (06) : 662 - 666
  • [3] Ovarian Serous Carcinoma: Relationship of p53 and bcl-2 With Tumor Angiogenesis and VEGF Expression
    Crasta, Julian A.
    Mishra, Suniti
    Vallikad, Elizabeth
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2011, 30 (06) : 521 - 526
  • [4] Prognostic significance of bcl-2 and p53 expression in colorectal carcinoma
    赵丹萍
    丁小文
    彭佳萍
    郑毅雄
    张苏展
    JournalofZhejiangUniversityScience, 2005, (12) : 1163 - 1169
  • [5] Bcl-2 protein expression: association with p53 and prognosis in colorectal cancer
    L Kaklamanis
    A Savage
    R Whitehouse
    I Doussis-Anagnostopoulou
    S Biddolph
    P Tsiotos
    N Mortensen
    KC Gatter
    AL Harris
    British Journal of Cancer, 1998, 77 : 1864 - 1869
  • [6] Bcl-2 protein expression: association with p53 and prognosis in colorectal cancer
    Kaklamanis, L
    Savage, A
    Whitehouse, R
    Doussis-Anagnostopoulou, I
    Biddolph, S
    Tsiotos, P
    Mortensen, N
    Gatter, KC
    Harris, AL
    BRITISH JOURNAL OF CANCER, 1998, 77 (11) : 1864 - 1869
  • [7] Prognostic significance of bcl-2 and p53 expression in colorectal carcinoma.
    Zhao D.P.
    Ding X.W.
    Peng J.P.
    Zheng Y.X.
    Zhang S.Z.
    Journal of Zhejiang University SCIENCE B, 2005, 6 (12): : 1163 - 1169
  • [8] Expression of Bcl-2 and p53 in the colorectal adenoma-carcinoma sequence
    Hao, XP
    Ilyas, M
    Talbot, IC
    PATHOBIOLOGY, 1997, 65 (03) : 140 - 145
  • [9] BCL-2 and p53 expression in endometrial carcinoma
    Erkanli, S
    Eren, F
    Pekin, S
    Bagis, T
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2004, 23 (01) : 97 - 103
  • [10] p53 and bcl-2 protein expression in colorectal cancer
    Manne, U
    Myers, RB
    Moron, C
    Srivastava, S
    Grizzle, WE
    LABORATORY INVESTIGATION, 1996, 74 (01) : 348 - 348